Literature DB >> 3139186

Convulsions associated with prophylactic antimalarial drugs: implications for people with epilepsy.

D R Fish1, M L Espir.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3139186      PMCID： PMC1840379          DOI： 10.1136/bmj.297.6647.526

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  CHLOROQUINE SUICIDE.

Authors:  F W KIEL
Journal:  JAMA       Date:  1964-10-26       Impact factor: 56.272

2.  Chloroquine seizures. Report of four cases.

Authors:  E F Torrey
Journal:  JAMA       Date:  1968-06-03       Impact factor: 56.272

3.  Central nervous system toxicity of pyrimethamine (daraprim) in man.

Authors:  R S GRISHAM
Journal:  Am J Ophthalmol       Date:  1962-12       Impact factor: 5.258
  3 in total
  10 in total

1.  Seizure associated with chloroquine therapy in a patient with systemic lupus erythematosus.

Authors:  Antonio G Tristano; Luz Falcón; María Willson; Ivette Montes de Oca
Journal:  Rheumatol Int       Date:  2004-01-23       Impact factor: 2.631

Review 2.  Ascertainment of risk of serious adverse reactions associated with chemoprophylactic antimalarial drugs.

Authors:  P A Phillips-Howard; A B Bjorkman
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

3.  [Use-risk consideration of anti-infective agents from the point of view of the licensing authority].

Authors:  W Christ; B Esch
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 4.  Clinical features, pathogenesis and management of drug-induced seizures.

Authors:  G Zaccara; G C Muscas; A Messori
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

5.  Risks and benefits of antimalarial drugs.

Authors:  D R Fish; M L Espir
Journal:  BMJ       Date:  1989-12-16

Review 6.  Antimalarial chemoprophylaxis in infants and children.

Authors:  M H Kramer; H O Lobel
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 7.  Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review.

Authors:  Sergio Marin; Alba Martin Val; Maite Bosch Peligero; Cristina Rodríguez-Bernuz; Ariadna Pérez-Ricart; Laia Vilaró Jaques; Roger Paredes; Josep Roca; Carles Quiñones
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-21

Review 8.  Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review.

Authors:  Adeel S Zubair; Lindsay S McAlpine; Tova Gardin; Shelli Farhadian; Deena E Kuruvilla; Serena Spudich
Journal:  JAMA Neurol       Date:  2020-08-01       Impact factor: 18.302

Review 9.  Antimalarial drug toxicity: a review.

Authors:  W Robert J Taylor; Nicholas J White
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 10.  CNS adverse events associated with antimalarial agents. Fact or fiction?

Authors:  P A Phillips-Howard; F O ter Kuile
Journal:  Drug Saf       Date:  1995-06       Impact factor: 5.606
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.